**LICENSE AGREEMENT**

This License Agreement (the “Agreement”) is made and entered into as of 2024/05/18 by and between MIT Press, located at 1600 Amphitheatre Parkway, Mountain View, CA 94043 (“Licensor”), and the National Institutes of Health, referred to as NIH and located at 221B Baker Street, London NW1 6XE, United Kingdom (“Licensee”).

**RECITALS**

WHEREAS, Licensor is the owner of certain copyrighted materials and has the right to grant licenses for the use thereof; and

WHEREAS, Licensee desires to obtain a license to use such materials for educational and research purposes;

NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties agree as follows:

**1. DEFINITIONS**

1.1 "Licensed Materials" means the books and online materials designated in Exhibit A, attached hereto and incorporated herein by reference.

1.2 "Authorized Users" means employees, students, faculty, and walk-in users affiliated with Licensee.

1.3 "Open Access" means content made available to the public at no cost. This agreement does not cover open access content.

**2. SCOPE OF AGREEMENT**

2.1 Licensor shall provide Licensee with access to the Licensed Materials.

2.2 The Licensed Materials shall be provided in digital format, accessible via IP address authentication and available in PDF format. Access to supplementary materials (e.g., datasets, code) shall be provided where available.

2.3 Technical contact for Springer Nature, is Lei Chen at lei.chen@springernature.com

**3. LICENSE GRANT / RIGHTS AND RESTRICTIONS**

3.1 Licensor grants to Licensee a non-exclusive, non-transferable license to permit Authorized Users to access and use the Licensed Materials for educational, research, and scholarly purposes.

3.2 Authorized Users may:

   (a) Download, print, and copy portions of the Licensed Materials for their own personal, educational, or research use.
   (b) Distribute single copies of portions of the Licensed Materials to other Authorized Users for educational or research purposes.
   (c) Use portions of the Licensed Materials for classroom teaching and presentations.

3.3 Authorized Users may not:

   (a) Remove or alter any copyright notices or other proprietary markings on the Licensed Materials.
   (b) Systematically download or reproduce substantial portions of the Licensed Materials.
   (c) Use the Licensed Materials for commercial purposes, including but not limited to resale, redistribution, or providing access to unauthorized users.

**4. AUTHORIZED USERS AND ACCESS**

4.1 Access to the Licensed Materials shall be restricted to Authorized Users.

4.2 Authorized Users shall be authenticated by IP address. The authorized IP address for access is 192.168.1.100.

4.3 Licensee shall take reasonable measures to prevent unauthorized access to and use of the Licensed Materials.

**5. FEES AND PAYMENT TERMS**

5.1 The total license fee for access to the Licensed Materials is EUR 8765.43.

5.2 Licensor shall invoice Licensee upon execution of this Agreement.

5.3 Licensee shall pay the invoice within thirty (30) days of receipt.

**6. TERM AND TERMINATION**

6.1 This Agreement shall commence on 2024/05/18 and shall continue for a term of one (1) year, unless terminated earlier as provided herein.

6.2 Either party may terminate this Agreement upon thirty (30) days written notice to the other party if the other party breaches any material term of this Agreement and fails to cure such breach within the thirty (30) day notice period.

6.3 Licensor may terminate this Agreement immediately upon written notice to Licensee if Licensee fails to pay any invoice within sixty (60) days of receipt.

**7. USAGE DATA AND REPORTING**

7.1 Licensor shall provide Licensee with COUNTER-compliant usage statistics on a quarterly basis.

7.2 The usage statistics shall include, at a minimum, the number of full-text articles downloaded and the number of searches performed.

7.3 Licensor shall provide reports on or before the 30th day following the end of each quarter (March 31, June 30, September 30, December 31).

**8. WARRANTIES AND DISCLAIMERS**

8.1 Licensor warrants that it has the right to grant the license granted herein.

8.2 EXCEPT AS EXPRESSLY PROVIDED HEREIN, LICENSOR MAKES NO WARRANTIES, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.

8.3 IN NO EVENT SHALL LICENSOR BE LIABLE FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, OR SPECIAL DAMAGES ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT, EVEN IF LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

**9. CONFIDENTIALITY**

9.1 The pricing terms of this Agreement are confidential and shall not be disclosed by either party to any third party without the prior written consent of the other party, except as required by law.

**10. INTELLECTUAL PROPERTY**

10.1 Licensor retains all right, title, and interest in and to the Licensed Materials, including all copyright and other intellectual property rights therein.

10.2 Nothing in this Agreement shall be construed as transferring any ownership rights in the Licensed Materials to Licensee.

**11. OPEN ACCESS TERMS**

11.1 Not applicable. This agreement does not have open access components.

**12. GOVERNING LAW AND DISPUTE RESOLUTION**

12.1 This Agreement shall be governed by and construed in accordance with the laws of the Commonwealth of Massachusetts, without regard to its conflict of laws principles.

12.2 Any dispute arising out of or in connection with this Agreement shall be resolved through good faith negotiation between the parties. If the parties are unable to resolve the dispute through negotiation, they shall submit the dispute to binding arbitration in Boston, Massachusetts, in accordance with the rules of the American Arbitration Association.

**13. FORCE MAJEURE**

13.1 Neither party shall be liable for any failure to perform its obligations under this Agreement if such failure is caused by a force majeure event, including but not limited to acts of God, war, terrorism, natural disasters, or government regulations.

**14. NOTICES**

14.1 All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given when delivered in person, by email, or three (3) business days after being mailed by registered or certified mail, return receipt requested, postage prepaid, to the addresses set forth below:

If to Licensor:
MIT Press
1600 Amphitheatre Parkway, Mountain View, CA 94043
Attn: Dirk Savage
Email: dirk.savage@mitpress.edu
Phone: +1 (234) 567-8901

If to Licensee:
National Institutes of Health (NIH)
P.O. Box 789, Anytown, USA 12345
Attn: Eleanor Vance
Email: eleanor.vance@nih.gov
Phone: +44 20 7946 0823

**15. ENTIRE AGREEMENT AND AMENDMENTS**

15.1 This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior or contemporaneous communications and proposals, whether oral or written.

15.2 This Agreement may be amended only by a written instrument signed by both parties.

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

**MIT Press**

By: ____________________________
Name:
Title:

**National Institutes of Health (NIH)**

By: ____________________________
Name:
Title:
